STATE STREET CORP - AVADEL PHARMACEUTICALS PLC ownership

AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 74 filers reported holding AVADEL PHARMACEUTICALS PLC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of AVADEL PHARMACEUTICALS PLC
ValueSharesWeighting
Q3 2023$312,152
-17.3%
30,306
+32.3%
0.00%
Q2 2023$377,491
-56.3%
22,906
-75.7%
0.00%
Q1 2023$864,695
-28.2%
94,399
-43.9%
0.00%
Q4 2022$1,204,498
+90.6%
168,226
+33.4%
0.00%
Q3 2022$632,000
+50.5%
126,135
-26.6%
0.00%
Q2 2022$420,000
-70.1%
171,952
-16.4%
0.00%
Q1 2022$1,406,000
-8.2%
205,794
+8.6%
0.00%
Q4 2021$1,531,000
-5.2%
189,516
+15.0%
0.00%
Q3 2021$1,615,000
+72.0%
164,784
+18.2%
0.00%
Q2 2021$939,000
-13.9%
139,464
+15.6%
0.00%
Q1 2021$1,091,000
+74.8%
120,693
+29.3%
0.00%
Q4 2020$624,000
+49.6%
93,316
+12.7%
0.00%
Q3 2020$417,000
+178.0%
82,798
+346.5%
0.00%
Q2 2020$150,000
-59.6%
18,542
-79.2%
0.00%
Q3 2019$371,000
+43.8%
89,1920.0%0.00%
Q2 2019$258,000
+101.6%
89,1920.0%0.00%
Q1 2019$128,000
-44.3%
89,1920.0%0.00%
Q4 2018$230,000
-41.3%
89,1920.0%0.00%
Q3 2018$392,000
-51.8%
89,192
-32.8%
0.00%
Q2 2018$813,000
-18.0%
132,662
-2.5%
0.00%
Q1 2018$992,000
+0.4%
136,110
+12.9%
0.00%
Q4 2017$988,000
+194.0%
120,537
+276.2%
0.00%
Q3 2017$336,000
-4.3%
32,043
+0.8%
0.00%
Q2 2017$351,000
+16.2%
31,782
+1.7%
0.00%
Q1 2017$302,000
-4.4%
31,259
+2.8%
0.00%
Q4 2016$316,00030,4010.00%
Other shareholders
AVADEL PHARMACEUTICALS PLC shareholders Q1 2017
NameSharesValueWeighting ↓
JW Asset Management, LLC 444,439$3,644,0003.88%
Broadfin Capital, LLC 2,591,721$21,252,0003.47%
ARMISTICE CAPITAL, LLC 1,688,000$13,842,0001.38%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,955,494$32,435,0001.28%
NEXTHERA CAPITAL LP 505,921$4,149,0000.76%
Perceptive Advisors 2,391,841$19,613,0000.65%
BRANDES INVESTMENT PARTNERS, LP 3,308,250$27,128,0000.55%
KNOTT DAVID M 158,555$1,300,0000.52%
Ativo Capital Management LLC 130,032$1,066,0000.28%
Tekla Capital Management LLC 624,288$5,119,0000.20%
View complete list of AVADEL PHARMACEUTICALS PLC shareholders